Neuralstem, Inc. (NASDAQ:CUR) [Trend Analysis] knocking active thrust in leading trading session, shares an raise of remains unchanged to 0.31 with about 362700 shares have changed hands in this session. Neuralstem, Inc. (CUR) released that it has reached over 50% enrollment in its Phase 2 clinical trial evaluating NSI-189, a novel neurogenic small molecule, for the treatment of major depressive disorder (MDD).
The ongoing Phase 2 MDD study is testing two doses (40mg QD and 40mg OFFER) of NSI-189, a small molecule in an oral tablet formulation. The multi-center, double-blind, placebo-controlled Phase 2 study plans to enroll a total of 220 moderately depressed patients at 12 trial sites. The primary efficacy endpoint is a reduction in depression symptoms, as measured by the Montgomery-Asberg Depression Rating Scale (MADRS). The stock is going forward its fifty-two week low with 63.16% and lagging behind from its 52-week high price with -84.18%.
Same, the positive performance for the quarter recorded as 3.33% and for the year was -80.13%, while the YTD performance remained at -69.90%. CUR has Average True Range for 14 days of 0.03.
Shares of Apple Inc. (NASDAQ:AAPL) [Trend Analysis] swings enthusiastically in regular trading session, it a loss of -0.02% to close at $113.55. Formula One team owner McLaren Technology Group has denied a reporttechnology giant Apple Inc. (AAPL) is in talks over a potential investment in the British luxury and supercar maker. “We can confirm that McLaren is not in discussion with Apple in respect of any potential investment,” stated McLaren. Earlier, the Financial Times reported that Apple was considering to buy a major stake in McLaren, however, it was not certain whether it’s a “strategic investment” or a full acquisition. Moving forward to saw long-term intention, the experts calculate Return on Investment of 28.30%. The stock is going forward its fifty-two week low with 27.60% and lagging behind from its 52-week high price with -6.33%. AAPL last month stock price volatility remained 1.62%.
Kate Spade & Firm (NYSE:KATE) [Trend Analysis] retains strong position in active trade, as shares scoring 0.22% to $18.42 in a active trade session, while looking at the shares volume, about 2.19 Million shares have changed hands in this session. KATE attains analyst recommendation of 1.90 with week’s performance of -1.76%. Investors looking additional ahead will note that the Price to next year’s EPS is 37.00%.